tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SAGE Stock Latest News

Sage Therapeutics resumed with an Underperform at BofA
The FlySage Therapeutics resumed with an Underperform at BofA
17d ago
BIIB
SAGE
SAGE Therapeutics Announces CMO Resignation and Interim Appointment
PremiumCompany Announcements
SAGE Therapeutics Announces CMO Resignation and Interim Appointment
23d ago
8K
SAGE
Sage Therapeutics Chief Medical Officer to step down
PremiumThe Fly
Sage Therapeutics Chief Medical Officer to step down
23d ago
SAGE
SAGE Therapeutics: Hold Rating Amid Gradual Growth Prospects and Market Challenges
PremiumRatings
SAGE Therapeutics: Hold Rating Amid Gradual Growth Prospects and Market Challenges
1M ago
SAGE
Sage Therapeutics price target established at JPMorgan
PremiumThe Fly
Sage Therapeutics price target established at JPMorgan
1M ago
SAGE
SAGE Therapeutics Faces Legal Challenges: Potential Impact on Financial Stability and Growth
PremiumCompany AnnouncementsSAGE Therapeutics Faces Legal Challenges: Potential Impact on Financial Stability and Growth
1M ago
SAGE
Hold Rating for SAGE Therapeutics: Inventory Challenges and Strategic Prospects
Premium
Ratings
Hold Rating for SAGE Therapeutics: Inventory Challenges and Strategic Prospects
1M ago
SAGE
SAGE Therapeutics’ Earnings Call: ZURZUVAE’s Success Amid Challenges
Premium
Company Announcements
SAGE Therapeutics’ Earnings Call: ZURZUVAE’s Success Amid Challenges
1M ago
SAGE
Sage Therapeutics price target lowered to $12 from $14 at Scotiabank
PremiumThe Fly
Sage Therapeutics price target lowered to $12 from $14 at Scotiabank
1M ago
BIIB
SAGE
Sage Therapeutics price target lowered to $7 from $9 at Baird
PremiumThe Fly
Sage Therapeutics price target lowered to $7 from $9 at Baird
1M ago
SAGE
Cautious Outlook on SAGE Therapeutics Amid Strategic Uncertainty and Pipeline Ambiguities
PremiumRatings
Cautious Outlook on SAGE Therapeutics Amid Strategic Uncertainty and Pipeline Ambiguities
1M ago
SAGE
Sage Therapeutics price target lowered to $8 from $9 at Canaccord
PremiumThe Fly
Sage Therapeutics price target lowered to $8 from $9 at Canaccord
1M ago
BIIB
SAGE
SAGE Therapeutics: Hold Rating Amid Uncertainty and Strategic Exploration
PremiumRatingsSAGE Therapeutics: Hold Rating Amid Uncertainty and Strategic Exploration
1M ago
SAGE
Hold Rating on SAGE Therapeutics Amid Underwhelming Sales and Strategic Uncertainties
Premium
Ratings
Hold Rating on SAGE Therapeutics Amid Underwhelming Sales and Strategic Uncertainties
1M ago
SAGE
Sage Therapeutics price target lowered to $12 from $14 at H.C. Wainwright
Premium
The Fly
Sage Therapeutics price target lowered to $12 from $14 at H.C. Wainwright
1M ago
SAGE
Sage Therapeutics Reports Strong 2024 Performance
PremiumCompany Announcements
Sage Therapeutics Reports Strong 2024 Performance
1M ago
SAGE
SAGE Therapeutics: Hold Rating Amid Financial Challenges and Uncertain Outlook
PremiumRatings
SAGE Therapeutics: Hold Rating Amid Financial Challenges and Uncertain Outlook
1M ago
SAGE
Sage Therapeutics says existing cash to support operations through mid-2027
PremiumThe Fly
Sage Therapeutics says existing cash to support operations through mid-2027
1M ago
SAGE
Sage Therapeutics reports Q4 EPS , consensus ($1.36)
PremiumThe Fly
Sage Therapeutics reports Q4 EPS , consensus ($1.36)
1M ago
SAGE
SAGE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsSAGE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
SAGE
Sage Therapeutics price target raised to $9 from $6 at Mizuho
Premium
The Fly
Sage Therapeutics price target raised to $9 from $6 at Mizuho
2M ago
BIIB
SAGE
Sage Rejects Biogen Bid but Could be Open to Other Offers
Premium
Market News
Sage Rejects Biogen Bid but Could be Open to Other Offers
2M ago
BIIB
SAGE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >